BXSDiagnostics•businesswire•
Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules
Sentiment:Positive (80)
Summary
(NYSE:BXS) SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--CyPath® Lung identifies incidentally found ground-glass lung nodules, leading to early diagnosis and timely treatment.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 9, 2025 by businesswire